Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome
Clinical trial NCT06186648 · RECRUITING
Trial details
- NCT number
- NCT06186648
- Sponsor
- French Innovative Leukemia Organisation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-21
- Primary completion
- 2028-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.